← Back to Search

DASH Diet for High Blood Pressure (DASH4D Trial)

N/A
Waitlist Available
Led By Nisa Maruthur, MD, MHS
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 18 or older
Diabetes Mellitus Type 2 defined by HbA1c ≥6.5% or treatment of diabetes with diabetes medication(s)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at the end of 5-week feeding period
Awards & highlights

DASH4D Trial Summary

This trial is testing the effects of a DASH-style diet and different sodium levels on blood pressure.

Who is the study for?
Adults with Type 2 Diabetes and blood pressure between 120-159/under 100 mmHg, who can eat on-site meals regularly, have stable weight, no other clinical trials or severe illnesses. Must not be pregnant or planning pregnancy, without significant dietary restrictions that affect adherence.Check my eligibility
What is being tested?
The DASH4D trial is testing the effects of a diabetes-modified DASH diet versus a typical American diet and the impact of low versus high sodium intake on blood pressure in people with Type 2 Diabetes through a controlled feeding study.See study design
What are the potential side effects?
There may not be direct side effects from participating as this trial involves dietary changes rather than medication. However, changes in diet can sometimes cause digestive discomfort or alterations in energy levels.

DASH4D Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I have Type 2 diabetes with an HbA1c of 6.5% or higher, or I am on diabetes medication.

DASH4D Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at the end of 5-week feeding period
This trial's timeline: 3 weeks for screening, Varies for treatment, and at the end of 5-week feeding period for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Systolic blood pressure (SBP)
Secondary outcome measures
Cardiovascular disease (CVD) risk percentage
Diastolic blood pressure (DBP)
Fasting glucose level
+11 more

DASH4D Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Comparison diet with higher sodiumExperimental Treatment2 Interventions
Dietary pattern that is typical of what many Americans eat, with sodium level of 3700 mg/day
Group II: DASH4D diet with lower sodiumActive Control2 Interventions
DASH-style dietary pattern, modified for people with diabetes, with sodium level of 1500 mg/day
Group III: DASH4D diet with higher sodiumActive Control2 Interventions
DASH-style dietary pattern, modified for people with diabetes, with sodium level of 3700 mg/day
Group IV: Comparison diet with lower sodiumActive Control2 Interventions
Dietary pattern that is typical of what many Americans eat, with sodium level of 1500 mg/day

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,274 Previous Clinical Trials
14,840,412 Total Patients Enrolled
Beth Israel Deaconess Medical CenterOTHER
839 Previous Clinical Trials
13,010,321 Total Patients Enrolled
Nisa Maruthur, MD, MHSPrincipal InvestigatorJohns Hopkins University

Media Library

DASH4D diet Clinical Trial Eligibility Overview. Trial Name: NCT04286555 — N/A
High Blood Pressure Research Study Groups: DASH4D diet with lower sodium, DASH4D diet with higher sodium, Comparison diet with lower sodium, Comparison diet with higher sodium
High Blood Pressure Clinical Trial 2023: DASH4D diet Highlights & Side Effects. Trial Name: NCT04286555 — N/A
DASH4D diet 2023 Treatment Timeline for Medical Study. Trial Name: NCT04286555 — N/A
High Blood Pressure Patient Testimony for trial: Trial Name: NCT04286555 — N/A
~3 spots leftby Jul 2024